The Food and Drug Administration (FDA) on Thursday...

MONDAY, March 23, 2026 — A stronger version of the popular weight loss drug Wegovy is on the way after federal regulators signed off on a higher...

PLAINSBORO, N.J., March 19, 2026 /PRNewswire/ -- Novo Nordisk today announced US Food and Drug Administration (FDA) approval of a new higher dose of...

The U.S. Food and Drug Administration announced on...

European drug regulators approved the higher-dose version of Wegovy in February.

European drug regulators approved the higher-dose version of Wegovy in February.

Side effects were more common with the higher dose....

Side effects were more common with the higher dose....

Novo Nordisk's FDA nod for higher-dose Wegovy could boost healthcare ETFs' appeal, offering diversified exposure to the obesity drug market.

CAMBRIDGE, Mass., March 30, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the High Dose Regimen of Spinraza (nusinersen),...